Neuronetics Launches National TMS Therapy Awareness Day
Neuronetics, Inc. (NASDAQ: STIM), a trailblazer in medical technology, is excited to introduce the inaugural National TMS Therapy Awareness Day. This celebration will take place every year in May, coinciding with Mental Health Awareness Month, with a dedicated focus on transcranial magnetic stimulation (TMS) treatment. The goal is to elevate awareness of TMS as an effective, non-drug therapy for those grappling with major depressive disorder (MDD), anxiety, and obsessive-compulsive disorder (OCD) – particularly for individuals who have not found relief through traditional antidepressants.
Empowering Patients Through Awareness
Keith Sullivan, the President and CEO of Neuronetics, emphasized the importance of this day, stating, "National TMS Awareness Day is about giving hope to people who haven’t found relief. We aim to drive the conversation around Mental Health Awareness, showing that options like NeuroStar TMS therapy can help people reclaim their lives." Millions experience frustration and despair after ineffective attempts at relief, and this initiative aims to ensure that patients, caregivers, and healthcare providers are informed about viable, non-medication treatment options.
What is Transcranial Magnetic Stimulation?
Transcranial magnetic stimulation received its first FDA clearance in 2008 for treating adults with treatment-resistant depression. Since its introduction, NeuroStar has emerged as a leader in this space, demonstrating commitment through quality and compassionate care. The FDA's recent approval has expanded NeuroStar TMS therapy's eligibility to adolescents, addressing a need for effective mental health treatments among younger individuals. With over 300 million Americans covered through insurance plans, including Medicare and Tricare, access to this therapy is becoming increasingly available.
The Science Behind NeuroStar TMS Therapy
Dr. Geoffrey Grammer, Chief Medical Officer at Neuronetics, explained that the dependability of NeuroStar TMS therapy is rooted in the precision of its technology. The unique coil design directs focused magnetic pulses precisely where they are needed, and the Contact Sensing feature allows for consistent and effective treatment sessions, maximizing patient benefits. Every participant is encouraged to feel the difference our technology makes.
Real Stories of Transformation
A poignant example of the therapy's impact is Kristen Gingrich, a clinical social worker and patient advocate. Having experienced struggles with depression since her teen years, Kristens's battle intensified after postpartum challenges. After exploring various traditional therapies, she discovered NeuroStar TMS therapy, which has significantly improved her quality of life. She is now sharing her journey across social media, inspiring many others to consider this treatment path.
Continuing the Mission at Upcoming Events
In conjunction with launching National TMS Therapy Awareness Day, Neuronetics is committed to furthering its mission by presenting new data at upcoming psychiatric meetings. The findings will analyze symptom changes associated with TMS for major depressive disorder, showcasing the effectiveness of their treatment protocols.
About Neuronetics
Neuronetics is invested in revolutionizing mental health awareness and treatment. Their NeuroStar Advanced Therapy offers a non-invasive, non-drug treatment option that can substantially enhance well-being for those with mental health disorders. Neuronetics is not only dedicated to providing innovative treatment solutions but also operates associated Greenbrook TMS centers throughout the nation, providing support for patients who seek therapies for MDD and other related disorders. With over 7.4 million treatments administered and backed by comprehensive clinical data, NeuroStar is at the forefront of mental health technology.
Frequently Asked Questions
What is National TMS Therapy Awareness Day?
It is a dedicated day to promote awareness about transcranial magnetic stimulation (TMS) therapy as an effective, non-drug treatment for mental health conditions.
How does NeuroStar TMS therapy work?
NeuroStar TMS therapy uses magnetic fields to stimulate nerve cells in the brain, targeting areas involved in mood regulation.
Who can benefit from TMS therapy?
TMS therapy is suitable for individuals suffering from major depressive disorder, anxiety, and OCD, especially those who haven’t found relief through medication.
Is TMS therapy approved by regulatory agencies?
Yes, TMS therapy is FDA-cleared for treatment-resistant depression, and the technology is continuously evolving to serve more patients effectively.
How can I learn more about NeuroStar's treatments?
For more information, you can visit the official NeuroStar website or reach out to their contact numbers provided in the media section.
